No products in the cart.
Mouse Monoclonal Tubulin beta antibody [2E9] (STJ98436)
Supplier: St John’s Laboratory Ltd.
Recommended applications: WB, IF, FC, ELISA
Recommended dilution: WB 1:500-1:2000; IF 1:200-1:1000; FC 1:200-1:400; ELISA 1:10000
Recommended protocols: check protocols
Click or hover above images to see image description for Tubulin beta Monoclonal Antibody.
Check alternative names for the antibodyExpand
TUBB3 antibody, TUBB4 antibody,|beta 3 tubulin antibody|beta-4 antibody|CDCBM antibody|CDCBM1 antibody|CFEOM3 antibody|CFEOM3A antibody|FEOM3 antibody|M(beta)3 antibody|M(beta)6 antibody|MC1R antibody|Neuron specific beta III Tubulin antibody|Neuron-specific class III beta-tubulin antibody|QccE-11995 antibody|QccE-15186 antibody|TBB3_HUMAN antibody|Tubb 3 antibody|TUBB3 antibody|TUBB4 antibody|Tubulin beta 3 antibody|Tubulin beta 3 chain antibody|Tubulin beta 4 antibody|Tubulin beta III antibody|Tubulin beta-3 chain antibody|Tubulin beta-4 chain antibody|Tubulin beta-III antibody|Anti-beta III Tubulin antibody [2G10] (ab78078)
SCBT cat No: sc-80005|sc-69966|
Tubulin beta Monoclonal Antibody
|Catalogue No.|| |
Tubulin beta Monoclonal Antibody detects endogenous levels of Tubulin beta protein.
Purified recombinant fragment of human Tubulin beta expressed in E Coli
WB, IF, FC, ELISA
|Recommended dilution|| |
WB 1:500-1:2000; IF 1:200-1:1000; FC 1:200-1:400; ELISA 1:10000
Tubulin beta Antibody was tube-contained. Ascitic fluid containing 0.03% sodium azide.
Tubulin beta Antibody was purified using affinity purification.
-20 Celsius degree. Avoid repeated freeze/thaw cycles.
|Alternative antibody names|| |
Tubulin beta-3 chain antibody, Tubulin beta-4 chain antibody, Tubulin beta-III antibody
|Protein names|| |
Tubulin beta-3 chain , Tubulin beta-4 chain , Tubulin beta-III
|Protein function|| |
Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain. TUBB3 plays a critical role in proper axon guidance and mantainance.
|Protein tissue specificity|| |
Expression is primarily restricted to central and peripheral nervous system. Greatly increased expression in most cancerous tissues.
|Involvement in disease|| |
Fibrosis of extraocular muscles, congenital, 3A (CFEOM3A) [MIM:600638]: A congenital ocular motility disorder marked by restrictive ophthalmoplegia affecting extraocular muscles innervated by the oculomotor and/or trochlear nerves. It is clinically characterized by anchoring of the eyes in downward gaze, ptosis, and backward tilt of the head. Congenital fibrosis of extraocular muscles type 3 presents as a non-progressive, autosomal dominant disorder with variable expression. Patients may be bilaterally or unilaterally affected, and their oculo-motility defects range from complete ophthalmoplegia (with the eyes fixed in a hypo- and exotropic position), to mild asymptomatic restrictions of ocular movement. Ptosis, refractive error, amblyopia, and compensatory head positions are associated with the more severe forms of the disorder. In some cases, the ocular phenotype is accompanied by additional features including developmental delay, corpus callosum agenesis, basal ganglia dysmorphism, facial weakness, polyneuropathy. . Note: The disease is caused by mutations affecting the gene represented in this entry.; Cortical dysplasia, complex, with other brain malformations 1 (CDCBM1) [MIM:614039]: A disorder of aberrant neuronal migration and disturbed axonal guidance. Affected individuals have mild to severe mental retardation, strabismus, axial hypotonia, and spasticity. Brain imaging shows variable malformations of cortical development, including polymicrogyria, gyral disorganization, and fusion of the basal ganglia, as well as thin corpus callosum, hypoplastic brainstem, and dysplastic cerebellar vermis. Extraocular muscles are not involved. . Note: The disease is caused by mutations affecting the gene represented in this entry.
|Protein sequence and domain|| |
The highly acidic C-terminal region may bind cations such as calcium. / Belongs to the tubulin family.
|Protein post-translational modifications|| |
Some glutamate residues at the C-terminus are polyglutamylated, resulting in polyglutamate chains on the gamma-carboxyl group . Polyglutamylation plays a key role in microtubule severing by spastin (SPAST). SPAST preferentially recognizes and acts on microtubules decorated with short polyglutamate tails: severing activity by SPAST increases as the number of glutamates per tubulin rises from one to eight, but decreases beyond this glutamylation threshold . / Some glutamate residues at the C-terminus are monoglycylated but not polyglycylated due to the absence of functional TTLL10 in human. Monoglycylation is mainly limited to tubulin incorporated into axonemes (cilia and flagella). Both polyglutamylation and monoglycylation can coexist on the same protein on adjacent residues, and lowering glycylation levels increases polyglutamylation, and reciprocally. The precise function of monoglycylation is still unclear (Probable). / Phosphorylated on Ser-172 by CDK1 during the cell cycle, from metaphase to telophase, but not in interphase. This phosphorylation inhibits tubulin incorporation into microtubules.
|Protein cellular localization|| |
Cytoplasm > cytoskeleton
AntibodyPlus can customize Tubulin beta Antibody according to your requirement, including bulk product size,etc. Please contact firstname.lastname@example.org. AntibodyPlus provide antibody trial sample for your own antibody validation and collects antibody reviews.
St John’s Laboratory Ltd.
|Product type|| |
There are no reviews for this product yet.
By submitting a review, get following benefits:
1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!
There is no extra validation for this product yet.
Check other extra validated antibodies below: